$589.53
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
McKesson
MCKNYSE
McKesson (NYSE:MCK) Stock, Analyst Ratings, Price Targets, Forecasts
McKesson Corp has a consensus price target of $534.7 based on the ratings of 70 analysis. The 3 most-recent analyst ratings were released by Baird, B of A Securities, and Argus Research on July 9, 2024, June 25, 2024, and June 24, 2024, respectively. With an average price target of $678 between Baird, B of A Securities, and Argus Research, there's an implied 15.01% upside for McKesson Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
B of A Securities
Argus Research
Deutsche Bank
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for McKesson
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 17.72% | Baird | Eric Coldwell | $679 → $694 | Maintains | Outperform | Get Alert |
| 06/25/2024 | Buy Now | 13.65% | B of A Securities | Michael Cherny | $590 → $670 | Maintains | Buy | Get Alert |
| 06/24/2024 | Buy Now | 13.65% | Argus Research | David Toung | $570 → $670 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | -7.55% | Deutsche Bank | George Hill | $547 → $545 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | -6.54% | Wells Fargo | Stephen Baxter | $502 → $551 | Maintains | Equal-Weight | Get Alert |
| 05/08/2024 | Buy Now | 1.1% | Barclays | Steve Valiquette | $571 → $596 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | 10.6% | TD Cowen | Charles Ryhee | $563 → $652 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 1.78% | Evercore ISI Group | Elizabeth Anderson | $590 → $600 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | 6.86% | UBS | Kevin Caliendo | $620 → $630 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 13.82% | Baird | Eric Coldwell | $603 → $671 | Maintains | Outperform | Get Alert |
| 04/30/2024 | Buy Now | 5.17% | Citigroup | Daniel Grosslight | $575 → $620 | Maintains | Buy | Get Alert |
| 04/15/2024 | Buy Now | -7.04% | Morgan Stanley | Erin Wright | $522 → $548 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | -3.31% | Argus Research | David Toung | $510 → $570 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 5.17% | UBS | Kevin Caliendo | $575 → $620 | Maintains | Buy | Get Alert |
| 02/26/2024 | Buy Now | 1.78% | Leerink Partners | Michael Cherny | → $600 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | Buy Now | -14.34% | Mizuho | Ann Hynes | $450 → $505 | Maintains | Neutral | Get Alert |
| 02/08/2024 | Buy Now | -2.46% | Citigroup | Daniel Grosslight | $530 → $575 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | -5.18% | UBS | Kevin Caliendo | $525 → $559 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | -14.85% | Wells Fargo | Stephen Baxter | → $502 | Initiates | → Equal-Weight | Get Alert |
| 12/11/2023 | Buy Now | -4.5% | TD Cowen | Charles Ryhee | $508 → $563 | Maintains | Outperform | Get Alert |
| 11/17/2023 | Buy Now | -12.81% | JP Morgan | Lisa Gill | $495 → $514 | Maintains | Overweight | Get Alert |
| 11/03/2023 | Buy Now | -23.67% | Mizuho | Ann Hynes | $427 → $450 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | -18.58% | Morgan Stanley | Erin Wright | $459 → $480 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | -18.58% | Argus Research | David Toung | $450 → $480 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | -17.73% | Credit Suisse | A.J. Rice | $450 → $485 | Maintains | Outperform | Get Alert |
| 08/07/2023 | Buy Now | -16.03% | TD Cowen | Charles Ryhee | $491 → $495 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | -18.58% | UBS | Kevin Caliendo | $470 → $480 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | -22.14% | Morgan Stanley | Erin Wright | $426 → $459 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | -27.57% | Mizuho | Ann Hynes | $390 → $427 | Maintains | Neutral | Get Alert |
| 06/29/2023 | Buy Now | -23.67% | Argus Research | David Toung | $430 → $450 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | -23.67% | Credit Suisse | Jonathan Yong | $430 → $450 | Maintains | Outperform | Get Alert |
| 05/09/2023 | Buy Now | -20.28% | B of A Securities | Michael Cherny | $450 → $470 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | -16.71% | TD Cowen | Charles Ryhee | $416 → $491 | Maintains | Outperform | Get Alert |
| 05/09/2023 | Buy Now | -19.43% | Baird | Eric Coldwell | $450 → $475 | Maintains | Outperform | Get Alert |
| 05/09/2023 | Buy Now | -33.85% | Mizuho | Ann Hynes | $376 → $390 | Maintains | Neutral | Get Alert |
| 05/09/2023 | Buy Now | -28.76% | Barclays | Steve Valiquette | $415 → $420 | Maintains | Overweight | Get Alert |
| 03/31/2023 | Buy Now | -28.76% | Citigroup | Daniel Grosslight | → $420 | Initiates | → Buy | Get Alert |
| 02/02/2023 | Buy Now | -27.74% | Morgan Stanley | Erin Wright | $420 → $426 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | -23.67% | Baird | Eric Coldwell | $445 → $450 | Maintains | Outperform | Get Alert |
| 01/31/2023 | Buy Now | -25.36% | UBS | Kevin Caliendo | $450 → $440 | Maintains | Buy | Get Alert |
| 01/11/2023 | Buy Now | -24.52% | Baird | Eric Coldwell | $440 → $445 | Maintains | Outperform | Get Alert |
| 01/06/2023 | Buy Now | -28.76% | Morgan Stanley | Ricky Goldwasser | $403 → $420 | Maintains | Overweight | Get Alert |
| 11/14/2022 | Buy Now | -36.22% | Mizuho | Ann Hynes | $345 → $376 | Maintains | Neutral | Get Alert |
| 11/02/2022 | Buy Now | -29.6% | Barclays | Steve Valiquette | $375 → $415 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | Buy Now | -25.36% | Baird | Eric Coldwell | $405 → $440 | Maintains | Outperform | Get Alert |
| 09/12/2022 | Buy Now | -27.06% | Argus Research | David Toung | $370 → $430 | Maintains | Buy | Get Alert |
| 08/22/2022 | Buy Now | -31.64% | Morgan Stanley | Ricky Goldwasser | $370 → $403 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | -34.69% | Credit Suisse | Jonathan Yong | $377 → $385 | Maintains | Outperform | Get Alert |
| 08/04/2022 | Buy Now | -41.48% | Mizuho | Ann Hynes | $331 → $345 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | -32.15% | Baird | Eric Coldwell | $386 → $400 | Maintains | Outperform | Get Alert |
| 08/04/2022 | Buy Now | -32.15% | UBS | Kevin Caliendo | $380 → $400 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -35.88% | Deutsche Bank | George Hill | $343 → $378 | Upgrade | Hold → Buy | Get Alert |
| 05/11/2022 | Buy Now | -36.05% | Credit Suisse | Jonathan Yong | $333 → $377 | Maintains | Outperform | Get Alert |
| 05/09/2022 | Buy Now | -43.85% | Mizuho | Ann Hynes | $280 → $331 | Maintains | Neutral | Get Alert |
| 04/18/2022 | Buy Now | -38.76% | Cowen & Co. | Charles Rhyee | $325 → $361 | Maintains | Outperform | Get Alert |
| 04/12/2022 | Buy Now | -37.24% | Morgan Stanley | Ricky Goldwasser | $292 → $370 | Maintains | Overweight | Get Alert |
| 02/08/2022 | Buy Now | -48.6% | UBS | Kevin Caliendo | $245 → $303 | Maintains | Buy | Get Alert |
| 02/07/2022 | Buy Now | -52.5% | Mizuho | Ann Hynes | $250 → $280 | Maintains | Neutral | Get Alert |
| 02/04/2022 | Buy Now | — | Deutsche Bank | George Hill | — | Downgrade | Buy → Hold | Get Alert |
| 01/07/2022 | Buy Now | -43.51% | Credit Suisse | Jailendra Singh | $230 → $333 | Upgrade | Neutral → Outperform | Get Alert |
| 12/20/2021 | Buy Now | -57.59% | Mizuho | Ann Hynes | — | Maintains | Neutral | Get Alert |
| 12/17/2021 | Buy Now | -50.47% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
| 12/09/2021 | Buy Now | -59.97% | Mizuho | Ann Hynes | — | Maintains | Neutral | Get Alert |
| 12/09/2021 | Buy Now | -50.81% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 12/06/2021 | Buy Now | -57.59% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 11/08/2021 | Buy Now | -60.99% | Credit Suisse | Jailendra Singh | — | Maintains | Neutral | Get Alert |
| 11/03/2021 | Buy Now | -61.16% | Mizuho | Ann Hynes | — | Maintains | Neutral | Get Alert |
| 11/02/2021 | Buy Now | -54.2% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | -59.29% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/09/2021 | Buy Now | -62% | Credit Suisse | Jailendra Singh | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for McKesson (MCK) stock?
The latest price target for McKesson (NYSE:MCK) was reported by Baird on July 9, 2024. The analyst firm set a price target for $694.00 expecting MCK to rise to within 12 months (a possible 17.72% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for McKesson (MCK)?
The latest analyst rating for McKesson (NYSE:MCK) was provided by Baird, and McKesson maintained their outperform rating.
When was the last upgrade for McKesson (MCK)?
The last upgrade for McKesson Corp happened on June 7, 2022 when Deutsche Bank raised their price target to $378. Deutsche Bank previously had a hold for McKesson Corp.
When was the last downgrade for McKesson (MCK)?
The last downgrade for McKesson Corp happened on February 4, 2022 when Deutsche Bank changed their price target from N/A to N/A for McKesson Corp.
When is the next analyst rating going to be posted or updated for McKesson (MCK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of McKesson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for McKesson was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating McKesson (MCK) correct?
While ratings are subjective and will change, the latest McKesson (MCK) rating was a maintained with a price target of $679.00 to $694.00. The current price McKesson (MCK) is trading at is $589.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.